A cewar rahoton na FMI, zaɓuɓɓukan magani sun haɗa da magungunan anti-rheumatic da ke canza cututtuka (methotrexate), magungunan anti-inflammatory marasa steroidal (naproxen, ibuprofen, celecoxib, meloxicam, da diclofenac), biologics (certolizumab pegol, secukinumab, infliximab), da kuma biosimilars.
Sami Samfuran Kwafin Rahoton:
https://www.futuremarketinsights.com/reports/sample/rep-gb-12345
Yanayin Kasuwar Magani Ankylosing Spondylitis
Manyan 'yan wasa a cikin kasuwar ankylosing spondylitis sun hada da Wyeth, Mitsubishi Tanabe, Schering-Plough, Takeda, Novartis AG, Amgen, Centocor, Abbott, Eisai, da Pfizer.
Kamar yadda jaridar Jami'ar Oxford ta buga, kusan kashi 1% na yawan jama'ar Amurka, miliyan 1.3-1.56 na yawan jama'ar Turai, da kuma miliyan 4.63-4.98 a Asiya Pacific suna fama da cutar sankarau. Hakanan, kasuwa yana ba da shaida mai yawan saka hannun jari a ɓangaren bincike don gabatar da sabbin dabaru.
Siffofin haɓakar inorganic kuma suna ba da gudummawa sosai ga haɓakar kasuwar maganin ankylosing spondylitis. Misali - Novartis AG, a cikin Janairu 2019, ya shiga cikin haɗin gwiwa tare da TrialSpark tare da manufar haɓaka damar marasa lafiya zuwa gwajin asibiti. Ana sa ran lokacin yin rajista zai gajarta, ta yadda zai hanzarta haɓaka sabbin hanyoyin kwantar da hankali.
A cikin Oktoba 2019, Hukumar Tarayyar Turai ta amince da Cosentyx don kula da cututtukan spondyloarthritis marasa radiyo. Mataki na gaba ya haɗa da ƙaddamar da aikace-aikacen sabunta tambarin ga FDA ta Amurka da amincewar bayanta, ana sa ran kasuwar za ta yi girma sosai.
“Yarjejeniyar” ita ce sauran dabarun da ake amfani da su. Misali - Izana Bioscience, a cikin Dec 2017, ya shiga yarjejeniyar lasisi ta duniya tare da Kamfanin Magunguna na Takeda don masana'antu, kasuwanci, da haɓaka Namilumab don magance cututtukan cututtukan fata.
Hakanan, Zydus Cadila, a cikin Nuwamba 2017, ya ƙaddamar da biosimilar Adalimumab a Indiya. An yi amfani da shi don magance ciwon ankylosing spondylitis, rheumatoid amosanin gabbai, yara idiopathic amosanin gabbai.
Ƙaddamarwa irin waɗannan suna ba da ƙarfi ga kasuwar spondylitis na ankylosing kuma halin da ake ciki yana iya kasancewa iri ɗaya a lokacin hasashen.
Nemi Cikakken TOC na wannan Rahoton tare da adadi: https://www.futuremarketinsights.com/toc/rep-gb-12345
Mabuɗin Cire Daga Nazarin Kasuwar Magani Ankylosing Spondylitis
- Magungunan da ba na steroidal anti-inflammatory suna jagorantar kasuwa kamar yadda ake kallon su a matsayin layin farko na maganin ankylosing spondylitis.
- Hanyar gudanarwa ta baka tana riƙe mafi girman kason kasuwa saboda sauƙin amfani.
- Ta rukuni na shekaru, "manyan" suna ba da gudummawa ga yawancin samar da kudaden shiga kamar yadda ankylosing spondylitis yakan fara farawa a lokacin girma.
- Arewacin Amurka, wanda Amurka ke jagoranta, yana riƙe da mafi girman kaso na kasuwa saboda ingantattun kayan aikin kiwon lafiya, yawan abubuwan da suka faru na ankylosing spondylitis, da sabbin abubuwa a cikin masana'antar harhada magunguna.
Ku Yi Mana Tambayoyinku Game da Wannan Rahoton:
https://www.futuremarketinsights.com/ask-question/rep-gb-12345
Kuna son ƙarin fahimta?
Kasuwancin ankylosing spondylitis na duniya an ƙaddamar da shi akan nau'in magunguna (Magungunan da ba na steroidal Anti-inflammatory, Magungunan Anti-inflammatory, Magungunan rigakafi, TNF Blockers, JAK Inhibitors, Steroids, Biologics, da Sauransu), hanyar gudanarwa (parenteral, na baka). ), aikace-aikace ( Manya, matasa), da kuma labarin kasa (Arewacin Amurka, Latin Amurka, Turai, Gabashin Asiya, Kudancin Asiya, Oceania, MEA).
Sashe na Maɓalli
Drug Class
- Magungunan Anti-inflammatory marasa steroidal
- Magungunan Anti-inflammatory
- Magungunan Immunosuppressive
- TNF Blockers
- Masu hana JAK
- Steroids
- Halittu
- wasu
Hanyar Gudanarwa
Aikace-aikace
Region
- Amirka ta Arewa
- Latin America
- Turai
- East Asia
- Kudancin Asia
- Oceania
- Gabas ta Tsakiya da Afirka
Game da Bayanin Kasuwanci na Gaba (FMI)
Hasashen Kasuwa na gaba (ƙungiyar binciken kasuwa ta ESOMAR da memba na Babban Cibiyar Kasuwancin New York) yana ba da zurfin fahimta game da abubuwan gudanarwa waɗanda ke haɓaka buƙatu a kasuwa. Yana bayyana damar da za ta ba da fifiko ga ci gaban kasuwa a sassa daban-daban dangane da Tushen, Aikace-aikacen, Tashar Talla da Ƙarshen Amfani a cikin shekaru 10 masu zuwa.
Saduwa da Mu:
Fadakarwar Kasuwa ta gaba
Naúrar Lamba: 1602-006, Jumeirah Bay 2, Lambun Filaye: JLT-PH2-X2A
Jumeirah Lakes Towers, Dubai
United Arab Emirates
ABUBUWAN DA ZA KU GUDU DAGA WANNAN LABARI:
- Game da Haɗin Kan Kasuwa na gaba (FMI) Hasashen Kasuwa na gaba (ƙungiyar bincike ta kasuwa ta ESOMAR da memba na Babban Cibiyar Kasuwancin New York) yana ba da zurfin fahimta game da abubuwan gudanarwa waɗanda ke haɓaka buƙatu a kasuwa.
- Ƙaddamarwa irin waɗannan suna ba da ƙarfi ga kasuwar spondylitis na ankylosing kuma halin da ake ciki yana iya kasancewa iri ɗaya a lokacin hasashen.
- Kasuwancin ankylosing spondylitis na duniya an ƙaddamar da shi akan nau'in magunguna (Magungunan da ba na steroidal Anti-inflammatory, Magungunan Anti-inflammatory, Magungunan rigakafi, TNF Blockers, JAK Inhibitors, Steroids, Biologics, da Sauransu), hanyar gudanarwa (parenteral, na baka). ), aikace-aikace ( Manya, matasa), da kuma labarin kasa (Arewacin Amurka, Latin Amurka, Turai, Gabashin Asiya, Kudancin Asiya, Oceania, MEA).
